This initiative is a key part of the drive to improve outcomes for sepsis – the number one cause of preventable deaths worldwide – highlighting the significant diagnostic challenges and importance of early intervention.
Sepsis affects over 25 million people every year, proving fatal in almost a third of cases. The Global Sepsis Alliance aims to save 800,000 lives a year by promoting events such as World Sepsis Day. This sponsorship agreement is part of Radiometer’s ongoing pledge to improve global healthcare, by increasing awareness of sepsis and providing medical professionals with the tools to help identify and treat the condition sooner, improving the odds of recovery.
Radiometer offers the broadest point-of-care diagnostic menu to support the current guidelines for the diagnosis and treatment of sepsis. Last year, the company launched a rapid procalcitonin (PCT) assay – the biomarker of choice to aid the diagnosis of sepsis – which offers results in less than 21 minutes with the AQT90 FLEX analyzer. Together with Radiometer’s portfolio of other relevant diagnostic and prognostic markers – including white blood cell count, CRP, creatinine, bilirubin, lactate and blood gases – this is helping to significantly improve turnaround times for sepsis diagnosis, improving the odds of patients making a full recovery.
Henrik Schimmell, President of Radiometer, commented: “We are delighted to be sponsoring the World Sepsis Day, as it complements our ongoing commitment to help improve global healthcare by providing reliable, fast and easy patient diagnosis. By raising awareness of sepsis, we can help to ensure that more people survive this potentially fatal condition.”
To find out more about World Sepsis Day, visit http://www.world-sepsis-day.org.
To find out more about Radiometer’s portfolio of acute care tests, please contact Radiometer or visit www.radiometer.com/sepsisdetection.